Argent Capital Management LLC raised its stake in Balchem Co. (NASDAQ:BCPC – Free Report) by 39.1% during the fourth quarter, HoldingsChannel reports. The fund owned 5,821 shares of the basic materials company’s stock after buying an additional 1,636 shares during the period. Argent Capital Management LLC’s holdings in Balchem were worth $949,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of the stock. Inspire Investing LLC grew its stake in shares of Balchem by 2.7% in the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock worth $413,000 after acquiring an additional 62 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Balchem by 1.5% during the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock valued at $757,000 after purchasing an additional 75 shares in the last quarter. Atomi Financial Group Inc. lifted its holdings in shares of Balchem by 6.1% during the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock valued at $295,000 after purchasing an additional 96 shares in the last quarter. Xponance Inc. lifted its holdings in Balchem by 5.2% in the second quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock valued at $315,000 after acquiring an additional 102 shares during the period. Finally, Benjamin Edwards Inc. lifted its holdings in Balchem by 6.6% in the second quarter. Benjamin Edwards Inc. now owns 2,231 shares of the basic materials company’s stock valued at $344,000 after acquiring an additional 138 shares during the period. 87.91% of the stock is owned by hedge funds and other institutional investors.
Balchem Trading Up 1.0 %
Shares of NASDAQ BCPC opened at $160.18 on Thursday. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The business has a fifty day simple moving average of $171.30 and a two-hundred day simple moving average of $170.80. The firm has a market cap of $5.21 billion, a PE ratio of 43.06, a price-to-earnings-growth ratio of 5.32 and a beta of 0.69. Balchem Co. has a twelve month low of $135.84 and a twelve month high of $186.03.
Balchem Increases Dividend
Analysts Set New Price Targets
BCPC has been the topic of several recent research reports. HC Wainwright raised their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.
View Our Latest Report on Balchem
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
See Also
- Five stocks we like better than Balchem
- Business Services Stocks Investing
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- Find and Profitably Trade Stocks at 52-Week Lows
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.